Olympus Co. (OTCMKTS:OLYMY – Get Free Report) saw a large increase in short interest in July. As of July 15th, there was short interest totaling 43,336 shares, an increase of 333,253.8% from the June 30th total of 13 shares. Based on an average daily trading volume, of 117,586 shares, the days-to-cover ratio is currently 0.4 days.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group cut shares of Olympus from a “buy” rating to a “neutral” rating in a research report on Monday, June 15th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Olympus has a consensus rating of “Hold”.
View Our Latest Report on Olympus
Olympus Price Performance
About Olympus
Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.
In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.
Further Reading
- Five stocks we like better than Olympus
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
